Tesa10+ip5（ 15mg*10vials）

Tesa10+Ip5 refers to a common peptide blend containing 10 mg of Tesamorelin and 5 mg of Ipamorelin.

What the Components Do

• Tesamorelin (10 mg): A synthetic growth hormone-releasing hormone (GHRH) analog. It stimulates the pituitary gland to release growth hormone and is clinically studied for reducing deep abdominal (visceral) fat.

• Ipamorelin (5 mg): A selective growth hormone secretagogue (GHRP) and ghrelin mimetic. It works alongside Tesamorelin to encourage steady growth hormone pulses without significantly spiking cortisol or prolactin.

Common Goals & Reported Uses

People typically explore this combination for:

• Targeted reduction of visceral (belly) fat

• Improved body composition (preserving lean mass while supporting fat loss)

• Enhanced recovery, sleep quality, and metabolic support

Safety and Important Considerations

• Compounded Status: These peptide blends are typically prepared by compounding pharmacies or sold as research chemicals, meaning they are not individually FDA-approved as a fixed-ratio combination product.

• Potential Side Effects: Can include injection-site reactions (pain, redness, bruising), mild fluid retention or joint stiffness/aches, and changes in blood sugar or glucose tolerance.

• Medical Guidance: Growth hormone-influencing peptides require proper screening because they are contraindicated in individuals with active cancer, history of pituitary disease, or certain metabolic conditions